Medicus Pharma (TSXV:MDCX) Interest Expense : C$-0.75 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medicus Pharma's interest expense for the three months ended in Mar. 2024 was C$ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.75 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medicus Pharma's Operating Income for the three months ended in Mar. 2024 was C$ -2.41 Mil. Medicus Pharma's Interest Expense for the three months ended in Mar. 2024 was C$ -0.01 Mil. Medicus Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medicus Pharma Interest Expense Historical Data

The historical data trend for Medicus Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Interest Expense Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

-0.15

-0.72

-0.99

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial					-0.26	-0.32	-0.41	-	-0.01

Medicus Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.75 Mil.

Medicus Pharma (TSXV:MDCX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medicus Pharma's Interest Expense for the three months ended in Mar. 2024 was C$-0.01 Mil. Its Operating Income for the three months ended in Mar. 2024 was C$-2.41 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was C$0.40 Mil.

Medicus Pharma's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Medicus Pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Medicus Pharma (TSXV:MDCX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (TSXV:MDCX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MDPLF:USA N46:Germany

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (TSXV:MDCX) Headlines

No Headlines